Market Tracker

07/23 7:39am ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

6.88
Data as of Jul 22
 +0.21 / +3.15%
Today’s Change
5.40
Today|||52-Week Range
11.88
-6.90%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close6.67
Today’s open6.73
Day’s range-- - --
Volume86,649
Average volume (3 months)86,482
Market cap$298.3M
Dividend yield--
Data as of 07/22/2014

Growth & Valuation

Earnings growth (last year)+76.89%
Earnings growth (this year)-84.69%
Earnings growth (next 5 years)--
Revenue growth (last year)+54.09%
P/E ratioNM
Price/Sales14.53
Price/Book3.08

Competitors

 Today’s
change
Today’s
% change
PTXPernix Therapeutics ...-0.21-2.54%
CARACara Therapeutics In...-0.02-0.15%
PPHMPeregrine Pharmaceut...+0.00+0.31%
TTPHTetraphase Pharmaceu...+0.23+2.10%
Data as of 07/22/2014

Financials

Next reporting dateAugust 12, 2014
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$19.6M
Annual profit (last year)-$18.7M
Net profit margin-95.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Kleanthis G. Xanthopoulos
Chief Scientific Officer
Neil W. Gibson
Corporate headquarters
San Diego, California

Forecasts